In Canada, Mitsui has invested an additional CDN$25 million in the BioAmber joint venture for 10% of the equity, increasing its stake from 30% to 40%. Mitsui will also play a stronger role in the commercialization of bio-succinic acid produced in Sarnia, providing dedicated resources alongside BioAmber’s commercial team. BioAmber will maintain a 60% controlling … Continue reading Mitsui invests $25M in BioAmber JV; raises stake, will “play a stronger role”